Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cartigenix HP with RestorCel
- Development stage
- Unknown
- Lead developer
- Calroy Health Sciences
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Cartigenix HP with RestorCel is a joint health dietary supplement developed by Calroy Health Sciences. It is formulated with RestorCel, a proprietary, patented blend of 13 standardized bioactive compounds derived from Indian frankincense (Boswellia serrata, standardized to boswellic acids, serratol, and tirucallic acids) and wild celery seed extract (Apium graveolens, standardized to apiin, bergapten, and seselin). The supplement is designed to support joint health at the structural level by promoting cartilage regeneration biomarkers, improving joint flexibility, reducing exercise-related stiffness, and enhancing overall mobility and comfort. Clinical evaluation across three published human studies (including a randomized, double-blind, placebo-controlled trial) demonstrated significant improvements in joint pain scores, walking distance, and cartilage metabolism markers within 90 days.
- Brand names
- Cartigenix HP
- Other names
- RestorCel
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Cartigenix HP with RestorCel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cartigenix HP with RestorCel.